Every supplement on the market claims to be “backed by science.” The phrase is nearly meaningless, because it covers everything from a rigorous multi-year trial in thousands of people to a study where a compound was dripped onto cells in a petri dish. Both get called research. Only one should change what you buy.
The good news is that you do not need a statistics degree to tell them apart. A handful of questions filters out most of the noise. This guide walks through them in rough order of how much they matter.
1. Was It Done in Humans?
Start here, because it eliminates a startling share of supplement marketing.
In vitro (cell) studies apply a compound directly to cells in a dish, often at concentrations you could never achieve by swallowing something. They are useful for exploring mechanisms and genuinely necessary early science. They tell you nothing about whether a capsule works.
Animal studies are a real step up — a whole living system with metabolism and organs — but rodent doses are frequently many times the human equivalent, and a great many promising animal findings evaporate in human trials.
Human studies are the only ones that can answer the question you care about.
When a product’s evidence page cites mouse work or cell work, the honest translation is “this is a plausible hypothesis nobody has confirmed in people yet.” That is not fraud. It is just much weaker than the marketing implies. Curcumin is the classic case: a genuinely fascinating molecule in laboratory work, and a much more modest performer in human trials, largely because of absorption. Our curcumin guide covers that gap.
2. Was It Randomized and Controlled?
Among human studies, the design determines what you can conclude.
Observational studies track people who already do something and look for associations. They are valuable for generating hypotheses and sometimes the only ethical option, but they cannot establish cause. The core problem is confounding: people who take supplements also tend to exercise more, eat better, smoke less, and see doctors more often. The supplement gets credit for the whole lifestyle. This is why “vitamin users live longer” headlines keep appearing and keep failing when tested properly.
Randomized controlled trials (RCTs) assign participants to supplement or placebo by chance, which distributes those hidden differences evenly. Double-blind means neither participants nor researchers know who got what — essential, because supplement outcomes like energy, sleep quality, mood, and pain are strongly placebo-responsive.
Systematic reviews and meta-analyses pool multiple trials. These sit at the top of the hierarchy, with one caveat worth remembering: pooling poor studies produces a poor conclusion with a more impressive-looking confidence interval.
3. Does the Dose Match the Product?
This is the single most practical check, and it is where a lot of technically-true marketing lives.
A company cites a study showing benefit at 600 mg of an ingredient, then sells a blend containing 50 mg. The study is real. The citation is accurate. The product cannot reproduce the result.
Three things to compare:
- Amount. Study dose versus label dose, per day, not per serving if servings differ.
- Form. Different forms absorb very differently. Magnesium oxide and magnesium glycinate are not interchangeable; our magnesium forms comparison shows why. Same for vitamin D2 versus D3.
- Standardization. For herbs, the active constituent percentage matters more than the raw milligrams. See our standardized extracts guide.
Proprietary blends make this check impossible by design — they list a combined total without individual amounts. That is reason enough to be skeptical, as we cover in how to read supplement labels.
4. What Was Actually Measured?
A study can be well designed and still not show what the headline claims, because of the outcome it chose.
Surrogate endpoints are stand-in markers: a blood level, an enzyme, an inflammatory marker. They are cheap and fast to measure and often reasonable proxies. But a supplement moving a marker is not the same as it improving your health, and the history of medicine includes several instances where a drug improved a marker while making real outcomes worse.
Clinical endpoints — how you sleep, how much pain you have, how far you can run, whether you get sick — are what you actually want, and they are more expensive and slower to study.
Also watch for:
- Subgroup findings. “No effect overall, but a benefit in men over 60 with low baseline levels” is a hypothesis for the next study, not a result. Slice data enough ways and something crosses the significance line by chance.
- Composite outcomes that bundle a serious event with a trivial one, so the trivial one drives the whole result.
- Outcome switching. Good trials pre-register what they will measure. When a paper’s headline result is not the one it set out to test, be suspicious.
5. How Big, How Long, and Who Paid?
Size. Twelve participants can be a legitimate pilot study; it cannot settle anything. Under roughly 50 people, treat findings as preliminary. Small trials are also where dramatic effect sizes come from, precisely because they are noisy.
Duration. Two weeks tells you about acute effects. Anything about joint health, bone density, cognition, or heart health needs months to years. A four-week trial claiming a longevity effect is not measuring what it says.
Population. A result in trained young male athletes may not transfer to sedentary 60-year-old women. Deficiency status matters enormously — supplements correcting a deficiency usually show effects that vanish in already-replete people. That single fact explains a large share of contradictory nutrition headlines, and it is why our nutrient deficiency signs guide treats baseline status as the starting question.
Funding. Industry funding does not invalidate a study — someone has to pay, and manufacturers often fund the only trials that exist. But industry-funded research does show a pattern of more favorable results, so it warrants closer reading of the methods, not automatic dismissal or automatic acceptance.
6. Has Anyone Replicated It?
A single study is a data point. Findings that fail to replicate are extremely common across all of science, and supplement research is no exception.
Before you reorganize your regimen around one exciting trial, ask whether independent groups have found the same thing. Where multiple good trials agree — creatine for high-intensity performance, for instance — confidence is warranted. Where one small study stands alone, patience is warranted. Many popular supplement beliefs trace back to exactly one study whose finding never held up, a pattern we document across our myth-busting posts.
7. Read the Study, Not the Headline
Health journalism compresses hard. Somewhere between the paper and the headline, “associated with a modest reduction in a marker” becomes “prevents disease.”
Two habits help enormously:
- Find the abstract. PubMed is free. The abstract states the design, the number of participants, the dose, the duration, and the actual result in a few hundred words. Reading it takes two minutes and defuses most headlines.
- Distinguish relative from absolute risk. “Cuts risk by 50%” sounds enormous. If the risk went from 2 in 1,000 to 1 in 1,000, that is a 50% relative reduction and a 0.1 percentage point absolute one. Reputable reporting gives both; marketing gives only the bigger number.
Two more red flags: preprints have not been peer-reviewed, and conference abstracts are often preliminary work that never becomes a full paper. Neither is worthless, but neither is settled.
A Practical Checklist
When you encounter a supplement claim, run this:
- Human study? If cells or animals, park it as a hypothesis.
- Randomized, controlled, blinded? If observational, it shows association, not cause.
- Does the study dose and form match the product on the shelf?
- Real outcome or a surrogate marker?
- How many people, for how long, and in whom?
- Pre-specified outcome, or a subgroup found after the fact?
- Who funded it, and has anyone independent replicated it?
If a claim survives all seven, it is worth taking seriously. Most do not — which is genuinely useful information, because the money you do not spend on underdosed hope is money available for the few things that hold up.
It is also worth remembering that even solid research describes averages across a group, not a prediction about you. Our guide on how to tell if a supplement is working covers evaluating your own results without fooling yourself, and how supplements are regulated explains why this burden falls on you in the first place.
Bottom Line
You can filter most supplement marketing with two questions — was it a randomized controlled trial in humans, and does the study dose match what is in the bottle? Add checks on the outcome measured, the sample size and duration, the funding, and whether anyone replicated it, and you are reading better than most health coverage. Nothing here requires expertise, just the willingness to spend two minutes on an abstract before spending money on a bottle. No supplement diagnoses, treats, cures, or prevents disease, and no study changes that.
This guide is educational and not medical advice. Talk to a qualified healthcare provider before starting any supplement, especially if you are pregnant, nursing, taking medication, or managing a health condition.